OCT Clinical Completes Enrollment for Phase III Influenza Study
OCT Clinical, one of Eastern Europe’s leading CROs, successfully recruits 440 patients to test the drug Ibuklin in treating influenza. ST. PETERSBURG, RUSSIA, November 25, 2019 /EINPresswire.com/ -- OCT Clinical Trials, a leading European CRO …